The American Association for the Advancement of Science and the prestigious journal ‘Science’ ranked research related to immunotherapy at the top of their list of scientific achievements this past year, contributing a “deep transformation” about the care cancer.
No coincidence that for the 2014 edition of the annual Scientific Symposium, the Ri.MED Foundation – which since 2008 has set up a high level research fellowship at the University of Pittsburgh – has chosen as topic the immunoregulation in organ transplantation and oncology. The immunology and the cancer’s genetic are now more than ever at the center of biomedical research and open new horizons.
According to Professor Levine, Scientific Director of the Foundation Ri.MED, “it is likely that the immune system has a cache of molecular and cellular weapons and regulatory processes in its arsenal that have yet to be discovered and fully characterized and – continues the Professor of Pittsburgh – a greater understanding of the immune system will provide numerous opportunities for clinical benefit “.
The keynote speaker in the international arena are meeting on 22 October in Milan, at the San Raffaele Congress Centre, to discuss the results of their research projects. Here is the program:
- Mark J. Shlomchik (Professor and Chair of Immunobiology University of Pittsburgh School of Medicine)
“B vs. DC: How We Get Autoimmune-T”
- Sarah Gaffen (Professor of Medicine University of Pittsburgh School of Medicine)
“IL-17 Signaling and Fungal Immunity: The Dark Side of Anti-Cytokine Therapy”
- Claudio Bordignon (Professor of Hematology “Vita-Salute” San Raffaele University)
“Suicide Gene-Modified Donor T Cells and T-Cell Depleted Stem Cell Transplants Display”
- Dario A.A. Vignali (Professor and Vice chair of Immunology at the University of Pittsburgh School of Medicine)
“Targeting Tregs in Tumors”
- Vincenzo Bronte (Professor University of Verona)
“Molecular and Metabolic Control of Antitumor Immunity by Myeloid Cells”
- Fadi G. Lakkis (Frank and Athena Sarris Professor of Transplantation Biology-Professor of Surgery, of Immunology and Medicine- Scientific Director, Thomas E. Starzl Transplantation Institute University of Pittsburgh School of Medicine)
“How Transplanted Organs are sensed by the Innate Immune System”
- Warren D. Shlomchik (Professor of Medicine and of Immunobiology Yale University school of Medicine)
“Mechanisms of Graft-versus-Host Disease and Graft-versus-Leukemia”
Each edition of the Symposium Ri.MED offers to its participants the opportunity to attend a preview presentation of important scientific results, often not yet disclosed.